title: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
authors.affiliation: Centro de Hematología y Medicina Interna de Puebla, 8B Sur 3710, 72530 Puebla, PUE, Mexico. gruiz1@puebla.megared.net.mx
authors.forename: Guillermo J
authors.initials: GJ
authors.lastname: Ruiz-Argüelles
authors.forename: David
authors.initials: D
authors.lastname: Gómez-Almaguer
authors.forename: Briceida
authors.initials: B
authors.lastname: López-Martínez
authors.forename: Olga G
authors.initials: OG
authors.lastname: Cantú-Rodríguez
authors.forename: José C
authors.initials: JC
authors.lastname: Jaime-Pérez
authors.forename: Oscar
authors.initials: O
authors.lastname: González-Llano
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000097:blood; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D016044:Fusion Proteins, bcr-abl / Q000097:blood; D006086:Graft vs Host Disease / Q000209:etiology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000191:economics; D018183:Transplantation Chimera; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D016044:Fusion Proteins, bcr-abl